Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07114276) titled 'Prospective Validation of Machine Learning Model to Predict Platinum Induced Nephrotoxicity in Cancer Patients' on Aug. 4.
Study Type: Observational [Patient Registry]
Primary Sponsor: Taipei Medical University
Condition:
Chemotherapy Side Effects
Machine Learning
Acute Kidney Injury
Acute Kidney Disease
Intervention:
Other: Machine learning models predictions of acute kidney injury and acute kidney disease
Recruitment Status: Recruiting
Date of First Enrollment: October 30, 2023
Target Sample Size: 110
Countries of Recruitment:
Taiwan
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07114276
P...